The publication of this podcast was funded by CSL Behring. The views and opinions expressed are exclusively those of the speakers.
In this section, which is directed towards the expertise of Prof. McElvaney, the discussion focuses specifically on the relevance of detecting and diagnosing Alpha 1 Antitrypsin Deficiency (AATD) for lung diseases, as well as consideration of other diagnostic techniques and standards of care options for patients with AATD.
Create your
podcast in
minutes
It is Free